Paul E. Clavijo, Ph.D.
Affiliations: | 2011 | Cell Biology & Molecular Genetics | University of Maryland, College Park, College Park, MD |
Area:
Molecular Biology, Cell Biology, ImmunologyGoogle:
"Paul Clavijo"Parents
Sign in to add mentor| Kenneth Frauwirth | grad student | 2011 | University of Maryland | |
| (Comparison of NF-kappaB regulation in naive and anergic primary CD8+ T lymphocytes.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Asuzu DT, Alvarez R, Fletcher PA, et al. (2022) Pituitary adenomas evade apoptosis via noxa deregulation in Cushing's disease. Cell Reports. 40: 111223 |
| Hu Z, Viswanathan R, Cheng H, et al. (2022) Inhibiting WEE1 and IKK-RELA Crosstalk Overcomes TNFα Resistance in Head and Neck Cancers. Molecular Cancer Research : McR |
| Valencia JC, Erwin-Cohen RA, Clavijo PE, et al. (2021) Myeloid derived suppressive cell expansion promotes melanoma growth and severity of autoimmunity by inhibiting CD40/IL-27 regulation in macrophages. Cancer Research |
| Lee MY, Robbins Y, Sievers C, et al. (2021) Chimeric antigen receptor engineered NK cellular immunotherapy overcomes the selection of T-cell escape variant cancer cells. Journal For Immunotherapy of Cancer. 9 |
| Ye W, Gunti S, Allen CT, et al. (2020) ASTX660, an antagonist of cIAP1/2 and XIAP, increases antigen processing machinery and can enhance radiation-induced immunogenic cell death in preclinical models of head and neck cancer. Oncoimmunology. 9: 1710398 |
| Greene S, Robbins Y, Mydlarz WK, et al. (2019) Inhibition of MDSC trafficking with SX-682, a CXCR1/2 inhibitor, enhances NK cell immunotherapy in head and neck cancer models. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research |
| Patel P, Sun L, Robbins Y, et al. (2019) Enhancing direct cytotoxicity and response to immune checkpoint blockade following ionizing radiation with Wee1 kinase inhibition. Oncoimmunology. 8: e1638207 |
| Sun L, Clavijo PE, Robbins Y, et al. (2019) Inhibiting myeloid-derived suppressor cell trafficking enhances T cell immunotherapy. Jci Insight. 4 |
| Das R, Coupar J, Clavijo PE, et al. (2018) Lymphotoxin-β receptor-NIK signaling induces alternative RELB/NF-κB2 activation to promote metastatic gene expression and cell migration in head and neck cancer. Molecular Carcinogenesis |
| Sun L, Moore E, Berman R, et al. (2018) WEE1 kinase inhibition reverses G2/M cell cycle checkpoint activation to sensitize cancer cells to immunotherapy. Oncoimmunology. 7: e1488359 |